Insider · CIK 0001709119
Engle Bridget E.
officer
Files at WFC (WELLS FARGO & COMPANY/MN). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Common Stock, $1 2/3 Par Value | +104,550 | $0.00 | $0 | 104,550 | Feb 7, 2025 |
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | FTax withholding Common Stock, $1 2/3 Par Value | -51,572 | $79.47 | $4.1M | 52,979 | Feb 7, 2025 |
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Common Stock, $1 2/3 Par Value | +4,600 | $0.00 | $0 | 57,579 | Feb 7, 2025 |
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | FTax withholding Common Stock, $1 2/3 Par Value | -2,348 | $79.47 | $187k | 55,230 | Feb 7, 2025 |
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Restricted Share Rightderivative | -104,550 | $0.00 | $0 | 185,866 | Feb 7, 2025 |
| Feb 5, 2025 | WFC WELLS FARGO & COMPANY/MN | MOption exercise Restricted Share Rightderivative | -4,600 | $0.00 | $0 | 3,196 | Feb 7, 2025 |
| Jan 28, 2025 | WFC WELLS FARGO & COMPANY/MN | AGrant or award Restricted Share Rightderivative | +33,504 | $0.00 | $0 | 33,504 | Jan 30, 2025 |
| Dec 10, 2024 | WFC WELLS FARGO & COMPANY/MN | AGrant or award Restricted Share Rightderivative | +7,796 | $0.00 | $0 | 7,796 | Dec 12, 2024 |
| Oct 22, 2024 | WFC WELLS FARGO & COMPANY/MN | AGrant or award Restricted Share Rightderivative | +288,899 | $0.00 | $0 | 288,899 | Oct 24, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.